Invesco Ltd. Codexis, Inc. Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Codexis, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 67,447 shares of CDXS stock, worth $161,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,447
Previous 33,731
99.96%
Holding current value
$161,198
Previous $160,000
13.13%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding CDXS
# of Institutions
139Shares Held
63.7MCall Options Held
37.7KPut Options Held
25.9K-
Opaleye Management Inc. Boston, MA9.5MShares$22.7 Million7.03% of portfolio
-
Casdin Capital, LLC New York, NY8.1MShares$19.4 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$16.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$11.3 Million0.0% of portfolio
-
Telemark Asset Management, LLC Boston, MA3MShares$7.17 Million1.17% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $157M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...